Specification: 28 tabs per box
1. Patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumors treated with imatinib and sunitinib.
2. Patients with metastatic colorectal cancer who have received chemotherapy including fluorouracil, oxaliplatin and irinotecan, anti-vegf treatment and anti-egfr (KRAS wild-type).
3. It is suitable for advanced liver cancer patients with drug resistance (failure) after dojime treatment.
We provide customers with quality products and services.
If you would like to leave us a comment please go to contact us